Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Jul 2025 for Cellectar Biosciences, Inc., €42k. Read the official filing
Filing timeline
BuySaleJarrod Longcor
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+8.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jarrod Longcor: trading record in brief
Jarrod Longcor is a declared insider of Cellectar Biosciences, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 8 December 2023 and the latest from 2 July 2025.
Purchases make up the whole of the open-market record (2 purchases, €50k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. In 2025 alone, the filings show 2 purchases and no sales.
Most recently, on 3 July 2025, the filings show an open-market purchase worth €42k in Cellectar Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jarrod Longcor
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
10,000 shares@ US$4.99Common StockSEC:0001104659-25-065572:0
Canonical exit: 30 Sept 2025 (T+90)
30,000 shares@ US$0.28100.0% of flowCommon StockSEC:0001104659-25-023121:0
Canonical exit: 10 Apr 2025 (T+90)
42,927 shares0Common StockSEC:0001104659-23-125484:0
3 of 3 declarations
